Uroguanylin
Overview
guanylate cyclase activator 2B (uroguanylin) | |
---|---|
Identifiers | |
Symbol | GUCA2B |
Entrez | 2981 |
HUGO | 4683 |
OMIM | 601271 |
RefSeq | NM_007102 |
UniProt | Q16661 |
Other data | |
Locus | Chr. 1 p34-p33 |
WikiDoc Resources for Uroguanylin |
Articles |
---|
Most recent articles on Uroguanylin Most cited articles on Uroguanylin |
Media |
Powerpoint slides on Uroguanylin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Uroguanylin at Clinical Trials.gov Clinical Trials on Uroguanylin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Uroguanylin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Uroguanylin Discussion groups on Uroguanylin Patient Handouts on Uroguanylin Directions to Hospitals Treating Uroguanylin Risk calculators and risk factors for Uroguanylin
|
Healthcare Provider Resources |
Causes & Risk Factors for Uroguanylin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Uroguanylin is a 16 amino acid peptide that is secreted by enterochromaffin cells in the duodenum and proximal small intestine. Guanylin acts as an agonist of the guanylyl cyclase receptor GC-C and regulates electrolyte and water transport in intestinal and renal epithelia.
See also
External links
- uroguanylin at the US National Library of Medicine Medical Subject Headings (MeSH)